Sumitomo Mitsui Trust Group Inc. Grows Position in Kenvue Inc. $KVUE

Sumitomo Mitsui Trust Group Inc. boosted its stake in shares of Kenvue Inc. (NYSE:KVUE) by 6.3% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 5,217,558 shares of the company’s stock after purchasing an additional 310,958 shares during the period. Sumitomo Mitsui Trust Group Inc. owned approximately 0.27% of Kenvue worth $90,003,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the stock. Diversify Advisory Services LLC grew its position in Kenvue by 11.7% during the 4th quarter. Diversify Advisory Services LLC now owns 52,765 shares of the company’s stock worth $908,000 after purchasing an additional 5,522 shares during the last quarter. Apollon Wealth Management LLC grew its position in Kenvue by 166.5% during the 4th quarter. Apollon Wealth Management LLC now owns 67,620 shares of the company’s stock worth $1,166,000 after purchasing an additional 42,246 shares during the last quarter. V Square Quantitative Management LLC grew its position in Kenvue by 32.5% during the 4th quarter. V Square Quantitative Management LLC now owns 66,124 shares of the company’s stock worth $1,141,000 after purchasing an additional 16,211 shares during the last quarter. OFI Invest Asset Management acquired a new stake in Kenvue during the 4th quarter valued at approximately $22,828,000. Finally, Oak Thistle LLC acquired a new stake in Kenvue during the 4th quarter valued at approximately $1,563,000. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Kenvue Stock Performance

KVUE opened at $17.26 on Tuesday. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.96 and a quick ratio of 0.68. The firm has a fifty day moving average price of $17.96 and a 200 day moving average price of $17.07. Kenvue Inc. has a 1 year low of $14.02 and a 1 year high of $25.17. The stock has a market cap of $33.14 billion, a P/E ratio of 22.41, a P/E/G ratio of 3.94 and a beta of 0.61.

Kenvue (NYSE:KVUE) last posted its earnings results on Tuesday, February 17th. The company reported $0.27 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.22 by $0.05. Kenvue had a net margin of 9.72% and a return on equity of 19.72%. The firm had revenue of $3.78 billion during the quarter, compared to analysts’ expectations of $3.68 billion. During the same period in the previous year, the business posted $0.26 EPS. The business’s revenue was up 3.2% compared to the same quarter last year. Equities research analysts anticipate that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, February 25th. Investors of record on Wednesday, February 11th were paid a $0.2075 dividend. This represents a $0.83 annualized dividend and a dividend yield of 4.8%. The ex-dividend date was Wednesday, February 11th. Kenvue’s payout ratio is currently 107.79%.

Wall Street Analysts Forecast Growth

Several analysts have commented on the stock. Canaccord Genuity Group lifted their price objective on shares of Kenvue from $17.00 to $18.00 and gave the company a “hold” rating in a research note on Wednesday, February 18th. Argus upgraded shares of Kenvue to a “hold” rating in a research note on Friday, March 6th. Weiss Ratings restated a “hold (c-)” rating on shares of Kenvue in a research note on Wednesday, April 8th. Citigroup lifted their price objective on shares of Kenvue from $18.00 to $20.00 and gave the company a “neutral” rating in a research note on Wednesday, February 18th. Finally, Barclays lifted their price objective on shares of Kenvue from $18.00 to $19.00 and gave the company an “equal weight” rating in a research note on Friday, March 6th. Three research analysts have rated the stock with a Buy rating and thirteen have issued a Hold rating to the stock. According to data from MarketBeat.com, Kenvue currently has an average rating of “Hold” and an average target price of $19.50.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.